Carmol Drugs Private Limited
About Carmol Drugs Private Limited
Data last updated:
Carmol Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC073378. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Simhadri Srinivasareddy and Madhusudhana Chenchireddi Reddy.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at H No 2 – 95 2nd Floor P No 456 Pragathi Nagar Opp: Jntuc, Hyderabad, Telangana, India – 500090.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Carmol Drugs has one previous CIN (Corporate Identification Number): U24232AP2011PTC073378. The current CIN is U24232TG2011PTC073378, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC073378 | Current |
| U24232AP2011PTC073378 | Previous |
Contact details
Carmol Drugs Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No 2 – 95 2nd Floor P No 456 Pragathi Nagar Opp: Jntuc, Hyderabad, Telangana, India – 500090
- IndustryPharma, API Manufacturers
To see the full contact details of Carmol Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Carmol Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Carmol Drugs Private Limited, buy the company report.
Financials of Carmol Drugs Private Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Carmol Drugs Private Limited, buy the company report.
Board of directors of Carmol Drugs Private Limited
Carmol Drugs has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Simhadri Srinivasareddy | Director | 28 Mar 2011 | 15 Years 7 Months | Current |
| Madhusudhana Chenchireddi Reddy | Director | 29 Dec 2018 | 7 Years 10 Months | Current |
| Srinivasa Alla Reddy | Director | 18 Mar 2011 | 15 Years 7 Months | Current |
Auditor
Carmol Drugs Private Limited is audited by M T R & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M T R & ASSOCIATES | FY 2021 | 008674S |
Shareholding
The shareholding of Carmol Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Carmol Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Carmol Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Carmol Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Carmol Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Carmol Drugs Private Limited, buy the company report.
Recent activity
Carmol Drugs Private Limited has 8 board changes on record since 2011: 3 appointments and 5 cessations. The latest: Jaya Bhanu Venkata Nageswara Rao Nalla ceased to be Additional Director on 10 May 2019.
Frequently asked questions
Carmol Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 March 2011 (15+ years old) and is registered under CIN U24232TG2011PTC073378.
Carmol Drugs has 3 current directors:
- Simhadri Srinivasareddy - Director
- Madhusudhana Chenchireddi Reddy - Director
- Srinivasa Alla Reddy - Director
The latest financial statements of Carmol Drugs on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
No. Carmol Drugs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Carmol Drugs is U24232TG2011PTC073378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Carmol Drugs was incorporated on 18 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jaya Bhanu Venkata Nageswara Rao Nalla ceased to be Additional Director on 10 May 2019. Madhusudhana Chenchireddi Reddy was appointed as Director on 29 Dec 2018. Rama Mangeswar Reddy Bobbiti ceased to be Additional Director on 01 Nov 2012. Carmol Drugs has 8 board changes on record in total.
The registered office of Carmol Drugs is at H No 2 – 95 2nd Floor P No 456 Pragathi Nagar Opp: Jntuc, Hyderabad, Telangana, India – 500090.
Carmol Drugs operates in the pharma industry, in the api manufacturers segment.
The compliance status of Carmol Drugs is active non-compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
